Heparin Antibodies in Intensive Care Unit Patients (HAICU) [clinicaltrials:NCT00283322]
Heparin Antibodies in Intensive Care Unit Patients (HAICU) [clinicaltrials:NCT00283322]
Bio2RDF identifier
NCT00283322
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00283322
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
biospec retention [clinicaltrials_vocabulary:biospec-retention]
Samples Without DNA
biospec_descr [clinicaltrials_vocabulary:biospec_descr]
Plasma. Patients consented for use to look for heparin antibodies in this study only.
brief summary [clinicaltrials_vocabulary:brief-summary]
Intensive care unit pat ...... eek of
hospitalization.
brief title [clinicaltrials_vocabulary:brief-title]
Heparin Antibodies in Intensive Care Unit Patients (HAICU)
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2006-05-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Venous Thromboembolism ...... en different ICU populations.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2006-01-25T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
Heparin Induced Thrombocytopenia
Thromboembolism
Thrombosis
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2007-12-03T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00283322
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Heparin Antibodies in Intensive Care Unit Patients (HAICU)
org study id [clinicaltrials_vocabulary:org-study-id]
HSC-MS-04-0312
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2004-11-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2007-12-01T00:00:00Z
identifier
clinicaltrials:NCT00283322
title
Heparin Antibodies in Intensive Care Unit Patients (HAICU)
@en
type
label
Heparin Antibodies in Intensive Care Unit Patients (HAICU) [clinicaltrials:NCT00283322]
@en